Dynavax Technologies Corp (DVAX)
11.98
+0.14
(+1.18%)
USD |
NASDAQ |
Apr 23, 13:14
Dynavax Technologies Shareholders Equity (Quarterly): 622.07M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 622.07M |
September 30, 2023 | 604.92M |
June 30, 2023 | 577.20M |
March 31, 2023 | 563.73M |
December 31, 2022 | 581.01M |
September 30, 2022 | 500.58M |
June 30, 2022 | 422.80M |
March 31, 2022 | 287.48M |
December 31, 2021 | 222.37M |
September 30, 2021 | 67.58M |
June 30, 2021 | 83.38M |
March 31, 2021 | 99.76M |
December 31, 2020 | 58.69M |
September 30, 2020 | 69.28M |
June 30, 2020 | 58.30M |
March 31, 2020 | 11.82M |
December 31, 2019 | 8.29M |
September 30, 2019 | 39.16M |
June 30, 2019 | 10.59M |
March 31, 2019 | 43.16M |
December 31, 2018 | 63.06M |
September 30, 2018 | 97.01M |
June 30, 2018 | 131.31M |
March 31, 2018 | 165.89M |
December 31, 2017 | 199.55M |
Date | Value |
---|---|
September 30, 2017 | 204.43M |
June 30, 2017 | 140.53M |
March 31, 2017 | 97.40M |
December 31, 2016 | 89.20M |
September 30, 2016 | 108.27M |
June 30, 2016 | 138.77M |
March 31, 2016 | 164.43M |
December 31, 2015 | 187.08M |
September 30, 2015 | 211.19M |
June 30, 2015 | 74.53M |
March 31, 2015 | 75.07M |
December 31, 2014 | 100.48M |
September 30, 2014 | 121.58M |
June 30, 2014 | 150.67M |
March 31, 2014 | 173.85M |
December 31, 2013 | 186.29M |
September 30, 2013 | 72.40M |
June 30, 2013 | 84.66M |
March 31, 2013 | 97.93M |
December 31, 2012 | 114.83M |
September 30, 2012 | 130.06M |
June 30, 2012 | 144.71M |
March 31, 2012 | 88.38M |
December 31, 2011 | 99.88M |
September 30, 2011 | 36.23M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.29M
Minimum
Dec 2019
622.07M
Maximum
Dec 2023
257.32M
Average
99.76M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
Supernus Pharmaceuticals Inc | 921.52M |
Ligand Pharmaceuticals Inc | 700.91M |
Pacira BioSciences Inc | 870.13M |
Esperion Therapeutics Inc | -454.99M |
PetIQ Inc | 221.21M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 997.10M |
Total Liabilities (Quarterly) | 375.02M |
Debt to Equity Ratio | 0.358 |
Current Ratio | 13.81 |
Net Debt Paydown Yield | -0.02% |